InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by HALBERT JON. Director active across 1 company, notably Caris Life Sciences, Inc.. Cumulatively, 3 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €851k. History available since 27 February 2025. The latest transaction was disclosed on 15 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations